TY - JOUR
T1 - Practical instructions for using drugs in CT and MR cardiac imaging
AU - Rovere, Giuseppe
AU - Meduri, Agostino
AU - Savino, Giancarlo
AU - Flammia, Francesco Ciriaco
AU - Lo Piccolo, Francesca
AU - Carafa, Maria Rachele Pia
AU - Larici, Anna Rita
AU - Natale, Luigi
AU - Merlino, Biagio
AU - Marano, Riccardo
PY - 2021
Y1 - 2021
N2 - The progressive increase in numbers of noninvasive cardiac imaging examinations broadens the spectrum of knowledge radiologists are expected to acquire in the management of drugs during CT coronary angiography (CTCA) and cardiac MR (CMR) to improve image quality for optimal visualization and assessment of the coronary arteries and adequate MR functional analysis. Aim of this review is to provide an overview on different class of drugs (nitrate, beta-blockers, ivabradine, anxiolytic, adenosine, dobutamine, atropine, dipyridamole and regadenoson) that can be used in CTCA and CMR, illustrating their main indications, contraindications, efficacy, mechanism of action, metabolism, safety, side effects or complications, and providing advices in their use.
AB - The progressive increase in numbers of noninvasive cardiac imaging examinations broadens the spectrum of knowledge radiologists are expected to acquire in the management of drugs during CT coronary angiography (CTCA) and cardiac MR (CMR) to improve image quality for optimal visualization and assessment of the coronary arteries and adequate MR functional analysis. Aim of this review is to provide an overview on different class of drugs (nitrate, beta-blockers, ivabradine, anxiolytic, adenosine, dobutamine, atropine, dipyridamole and regadenoson) that can be used in CTCA and CMR, illustrating their main indications, contraindications, efficacy, mechanism of action, metabolism, safety, side effects or complications, and providing advices in their use.
KW - Adenosine
KW - Adrenergic beta-Antagonists
KW - Anti-Anxiety Agents
KW - Atropine
KW - Computed Tomography Angiography
KW - Contraindications
KW - Coronary Vessels
KW - Dipyridamole
KW - Dobutamine
KW - Ivabradine
KW - Magnetic Resonance Imaging
KW - Regadenoson
KW - Adenosine
KW - Adrenergic beta-Antagonists
KW - Anti-Anxiety Agents
KW - Atropine
KW - Computed Tomography Angiography
KW - Contraindications
KW - Coronary Vessels
KW - Dipyridamole
KW - Dobutamine
KW - Ivabradine
KW - Magnetic Resonance Imaging
KW - Regadenoson
UR - https://publicatt.unicatt.it/handle/10807/273347
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85089783970&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089783970&origin=inward
U2 - 10.1007/s11547-020-01261-4
DO - 10.1007/s11547-020-01261-4
M3 - Article
SN - 0033-8362
VL - 126
SP - 356
EP - 364
JO - LA RADIOLOGIA MEDICA
JF - LA RADIOLOGIA MEDICA
IS - 3
ER -
